Patents by Inventor Vasanthi Ramachandran

Vasanthi Ramachandran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11590142
    Abstract: Compounds of Formula I, its stereoisomers, pharmaceutically acceptable salts, complexes, hydrates, solvates, tautomers, polymorphs, racemic mixtures, optically active forms and pharmaceutically active derivative thereof and pharmaceutical compositions containing them as the active ingredient which can be used as medicaments are provided. The aforementioned substances can also be used in the manufacture of medicaments for treatment, prevention, or suppression of diseases, and conditions mediated by microbes. Methods for the synthesis and characterization of the aforementioned substances are also provided.
    Type: Grant
    Filed: March 28, 2019
    Date of Patent: February 28, 2023
    Assignee: BUGWORKS RESEARCH, INC.
    Inventors: Shahul Hameed Peer Mohamed, Nagakumar Bharatham, Nainesh Katagihallimath, Sreevalli Sharma, Radha Nandishaiah, Vasanthi Ramachandran
  • Patent number: 11401277
    Abstract: The invention relates to compounds of Formula I and Formula (B) along with their stereoisomers, pharmaceutically acceptable salts, complexes, hydrates, solvates, tautomers, polymorphs, racemic mixtures, optically active forms, and pharmaceutically active derivatives thereof. These compounds are useful for killing or inhibiting the growth of a microorganism selected from the group consisting of bacteria, virus, fungi, and protozoa.
    Type: Grant
    Filed: November 29, 2018
    Date of Patent: August 2, 2022
    Assignee: BUGWORKS RESEARCH, INC.
    Inventors: Shahul Hameed Peer Mohamed, Nagakumar Bharatham, Nainesh Katagihallimath, Sreevalli Sharma, Radha Nandishaiah, Vasanthi Ramachandran
  • Publication number: 20210070772
    Abstract: The invention relates to compounds of Formula I and Formula (B) along with their stereoisomers, pharmaceutically acceptable salts, complexes, hydrates, solvates, tautomers, polymorphs, racemic mixtures, optically active forms, and pharmaceutically active derivatives thereof. These compounds are useful for killing or inhibiting the growth of a microorganism selected from the group consisting of bacteria, virus, fungi, and protozoa.
    Type: Application
    Filed: November 29, 2018
    Publication date: March 11, 2021
    Inventors: Shahul Hameed PEER MOHAMED, Nagakumar BHARATHAM, Nainesh KATAGIHALLIMATH, Sreevalli SHARMA, Radha NANDISHAIAH, Vasanthi RAMACHANDRAN
  • Patent number: 10912780
    Abstract: The present disclosure relates to compounds of Formula I, or their stereoisomers, pharmaceutically acceptable salts, complexes, hydrates, solvates, tautomers, polymorphs, racemic mixtures, optically active forms and pharmaceutically active derivatives thereof, and pharmaceutical compositions containing them as the active ingredient which can be used as medicaments. The aforementioned substances can also be used in the manufacture of medicaments for treatment, prevention or suppression of diseases, and conditions mediated by microbes. The present disclosure also relates to the synthesis and characterization of aforementioned substances.
    Type: Grant
    Filed: June 8, 2018
    Date of Patent: February 9, 2021
    Assignee: Bugworks Research, Inc.
    Inventors: Shahul Hameed Peer Mohamed, Nagakumar Bharatham, Nainesh Katagihallimath, Sreevalli Sharma, Radha Nandishaiah, Vasanthi Ramachandran, Balasubramanian Venkataraman
  • Publication number: 20210008078
    Abstract: The present disclosure relates to compounds of Formula I, its stereoisomers, pharmaceutically acceptable salts, complexes, hydrates, solvates, tautomers, polymorphs, racemic mixtures, optically active forms and pharmaceutically active derivative thereof and pharmaceutical compositions containing them as the active ingredient which can be used as medicaments. The aforementioned substances can also be used in the manufacture of medicaments for treatment, prevention, or suppression of diseases, and conditions mediated by microbes. The present disclosure also relates to the synthesis and characterization of aforementioned substances.
    Type: Application
    Filed: March 28, 2019
    Publication date: January 14, 2021
    Inventors: Shahul Hameed PEER MOHAMED, Nagakumar BHARATHAM, Nainesh KATAGIHALLIMATH, Sreevalli SHARMA, Radha NANDISHAIAH, Vasanthi RAMACHANDRAN
  • Publication number: 20200085834
    Abstract: The present disclosure relates to compounds of Formula I, or their stereoisomers, pharmaceutically acceptable salts, complexes, hydrates, solvates, tautomers, polymorphs, racemic mixtures, optically active forms and pharmaceutically active derivatives thereof, and pharmaceutical compositions containing them as the active ingredient which can be used as medicaments. The aforementioned substances can also be used in the manufacture of medicaments for treatment, prevention or suppression of diseases, and conditions mediated by microbes. The present disclosure also relates to the synthesis and characterization of aforementioned substances.
    Type: Application
    Filed: June 8, 2018
    Publication date: March 19, 2020
    Inventors: Shahul Hameed PEER MOHAMED, Nagakumar BHARATHAM, Nainesh KATAGIHALLIMATH, Sreevalli SHARMA, Radha NANDISHAIAH, Vasanthi RAMACHANDRAN, Balasubramanian VENKATARAMAN
  • Patent number: 5380648
    Abstract: Induction of virulence related proteins in virulent pathogenic E. coli and Shigella by growing such bacteria in the presence of Congo Red as induction triggering factor, and the application of the induction for purposes of diagnosing virulent pathogens and their antibiotic sensitivity.
    Type: Grant
    Filed: April 5, 1990
    Date of Patent: January 10, 1995
    Assignee: Aktiebolaget Astra
    Inventors: Shanmugam Elango, Shantha Rajarathnam, Vasanthi Ramachandran, Raman K. Roy, Krishnan Sankaran, Yerramilli V. B. Subrahmanyam